Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-009489
Filing Date
2024-12-05
Accepted
2024-12-05 17:24:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4169
  Complete submission text file 0001950047-24-009489.txt   5739
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Subject) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36156 | Film No.: 241529952
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O GENOMIC HEALTH, INC. 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063
Business Address
Febbo Phillip G. (Reporting) CIK: 0001649245 (see all company filings)

Type: 144